In recent years, more and more celebrities — like Elon Musk and Whoopi Goldberg — have spoken up about using GLP-1 ...

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

In 2024, several celebrities made headlines with their remarkable weight loss journeys, inspiring millions by prioritizing ...

Our beauty icons range from legendary models like Iman and Alek Wek ... Cosmetic procedures such as nose jobs and the ...

A study in pigs has shown that the active ingredient in Ozempic and Wegovy directly boosts heart health, in addition to the ...

Novo and Valo originally partnered in September 2023 in an agreement to develop up to 11 drugs. With the expanded agreement, ...

By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers found. Common adverse side effects from the drugs included nausea, vomiting, ...

Wegovy is considered a safe and effective treatment for long-term weight loss. Possible problems with long-term use to discuss with your doctor include pancreatitis, gallbladder disease, and ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it could happen much sooner than later. The analysts pointed to ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...